Skip to main content
. 2013 Sep 11;17(5):R196. doi: 10.1186/cc12890

Figure 3.

Figure 3

FiO2 selected by IntelliVent-ASV: FiO2 for normal lung patients, ARDS and COPD patients. For each lung condition, all patients, passive patients and active patients are shown on the left, middle and right box plot, respectively. Comparisons used a Kruskal-Wallis analysis of variance with a Dunn's post hoc test. *P ≤0.05. ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; FiO2, inspiratory fraction of oxygen (%).